Iovance Biotherapeutics Inc (IOVA)
Cost of Revenue
$43.60M
Quarterly · Period ending: · USD
IOVA Cost of Revenue
Latest reported$43.60Mperiod ending
Latest reported$43.60Mperiod ending
IOVA Quarterly Cost of Revenue ($0.00 → $43.60M)
Quarterly cost of revenue
High-resolution chart · PNG
IOVA cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 43,595,000 | |
| 42,498,000 | |
| 43,111,000 | |
| 38,477,000 | |
| 48,881,000 | |
| 42,715,000 | |
| 45,543,000 | |
| 39,823,000 | |
| 31,368,000 | |
| 7,261,000 | |
| 4,365,000 | |
| 4,340,000 | |
| 2,050,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 290,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 2,660,000 | |
| 0 | |
| 0 | |
| 9,336,000 | |
| 2,449,000 | |
| 1,749,000 | |
| 1,957,000 | |
| 4,655,000 | |
| 0 | |
| 779,260 | |
| 0 | |
| 6,477,000 | |
| 1,378,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |